NEW YORK (GenomeWeb News) – Roche said today that it has completed the tender offer for Ventana’s outstanding shares and that it expects to wrap up the acquisition of the firm later today “without a vote or meeting of Ventana’s shareholders.”
 
Roche said that its wholly owned subsidiary Rocket Acquisition Corporation has purchased 34,545,323 shares of Ventana common stock, representing approximately 93.7 percent of the company’s outstanding shares. The total value of the purchase is around $3.4 billion.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.